Approval · Notice of Compliance 34480 · 2024
SOHONOS: Notice of Compliance 34480
Issued December 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34480
- Date
- December 3, 2024
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a manufacturing site and/or manufacturer involving production of the starting material
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOHONOS | Not yet assigned | — |
Medicinal ingredients
- PALOVAROTENE 1 MG per CAP
- PALOVAROTENE 1.5 MG per CAP
- PALOVAROTENE 2.5 MG per CAP
- PALOVAROTENE 5 MG per CAP
- PALOVAROTENE 10 MG per CAP